Recombinant Human ATP11C Protein，GST

The study of ATP11C recombinant protein has gained significant attention in recent years due to its pivotal role in cellular processes, particularly in the context of immune response and cellular ion homeostasis. ATP11C, a member of the P-type ATPase family, is primarily expressed in hematopoietic tissues and is crucial for maintaining the lipid asymmetry of the plasma membrane. Dysregulation of ATP11C function has been implicated in various immunological disorders, affecting T cell development and function. Furthermore, research has shown that ATP11C contributes to the transport of phospholipids, which are essential for membrane integrity and signaling. Given its critical functions, recombinant ATP11C protein is being explored as a potential therapeutic target for autoimmune diseases and cancers where its expression and function may be altered. Advanced techniques in recombinant protein expression help elucidate the structural and functional properties of ATP11C, providing insights into its mechanistic roles within the cell. Researchers are particularly interested in producing and characterizing ATP11C recombinant protein to develop specific inhibitors or modulators that could offer novel avenues for treatment. Moreover, studying ATP11C may also shed light on fundamental biological mechanisms governing membrane dynamics and cellular communication, thus further enhancing our understanding of both normal physiology and pathological conditions. Overall, ATP11C serves as a promising candidate for further investigation, with potential implications for therapeutic intervention in diseases associated with immune dysregulation and cellular dysfunction.